TACHYARRHYTHMIAS IN PATIENTS WITH CANCER
| Autor: | D P Doundoua, E G Chelombit'ko, Sergey V. Korolev, E. V. Plokhova, A V Konev |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment cardiotoxicity lcsh:Medicine chemotherapy Ventricular tachycardia Sudden cardiac death Internal medicine medicine cardiovascular diseases Proarrhythmia Cardiotoxicity tachyarrhythmia business.industry lcsh:R Cancer medicine.disease supraventricular tachycardia oncology Ventricular fibrillation cardiooncology cardiovascular system Cardiology arrhythmogenic action ventricular tachycardia Supraventricular tachycardia Cardiac monitoring business |
| Zdroj: | Клиническая практика, Vol 8, Iss 4, Pp 76-89 (2017) |
| ISSN: | 2618-8627 2220-3095 |
| DOI: | 10.17816/clinpract8476-89 |
| Popis: | Arrhythmia is often detected in cancer patient, from single ventricular premature contractions to sustained ventricular tachycardia, life threatening ventricular fibrillation and sudden cardiac death. Oncology per se, aggressive anticancer treatment, both chemotherapy and radiation and basic cardiac conditions are main causative factors for tachyarrhythmia. In this review we summarize evidence of arrhythmia and emphasize the importance of cardiac monitoring for the early diagnosis, intervention and surveillance of those patients more susceptible to develop proarrhythmia. Oncologists should be fully aware of arrhythmia and the close collaboration between cardiologists and oncologists would result in a better cardiovascular assessment, risk stratification, cardiac monitoring and treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|